within Pharmacolibrary.Drugs.R_RespiratorySystem.R01A_DecongestantsAndOtherNasalPreparationsForTopicalUse.R01AC51_CromoglicicAcidCombinations;

model CromoglicicAcidCombinations
  extends Pharmacolibrary.Drugs.ATC.R.R01AC51;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>R01AC51</td></tr><td>route:</td><td>nasal</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Cromoglicic acid (also known as cromolyn sodium) is a mast cell stabilizer used as a prophylactic treatment for allergic rhinitis and conjunctivitis, as well as for asthma and other allergic conditions. Combinations with other drugs may be used for upper respiratory tract allergies. It is approved in some countries for these uses, but in others its use has declined due to more effective alternatives.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic data specific for combinations of cromoglicic acid with ATC code R01AC51 (nasal administration) were identified in publicly available literature as of 2024. Estimates are provided based on data for cromoglicic acid nasal formulations in healthy adults.</p><h4>References</h4><ol><li><p>Sweeney, GD, &amp; MacLeod, SM (1989). Anti-allergy and anti-asthma drugs. Disposition in infancy and childhood. <i>Clinical pharmacokinetics</i> 17 Suppl 1 156–168. DOI:<a href=&quot;https://doi.org/10.2165/00003088-198900171-00011&quot;>10.2165/00003088-198900171-00011</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2692938/&quot;>https://pubmed.ncbi.nlm.nih.gov/2692938</a></p></li><li><p>Weiser, M, et al., &amp; Klein, P (1999). A randomized equivalence trial comparing the efficacy and safety of Luffa comp.-Heel nasal spray with cromolyn sodium spray in the treatment of seasonal allergic rhinitis. <i>Forschende Komplementarmedizin</i> 6(3) 142–148. DOI:<a href=&quot;https://doi.org/10.1159/000021239&quot;>10.1159/000021239</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/10460983/&quot;>https://pubmed.ncbi.nlm.nih.gov/10460983</a></p></li><li><p>McMartin, C, et al., &amp; Peters, GE (1987). Analysis of structural requirements for the absorption of drugs and macromolecules from the nasal cavity. <i>Journal of pharmaceutical sciences</i> 76(7) 535–540. DOI:<a href=&quot;https://doi.org/10.1002/jps.2600760709&quot;>10.1002/jps.2600760709</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2889824/&quot;>https://pubmed.ncbi.nlm.nih.gov/2889824</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end CromoglicicAcidCombinations;
